GSK PLC Requests to Dismiss Class Action Filed by Investors

Court: E.D. Pennsylvania

Case: 2:25-cv-00618

GSK PLC has requested the court to dismiss the lawsuit filed by investors. The court will determine whether the case proceeds.

What is this lawsuit about?

On August 10, 2022, a Deutsche Bank report revealed that GSK could face between $5 billion and $10 billion in liability related to Zantac lawsuits—contradicting prior company statements.

Following this, GSK dropped over 10%.

Then, on February 4, 2025, shareholders filed a claim against GSK PLC.

What can you do to recover your losses now?

We’re keeping track of all updates and will notify GSK investors about potential recovery.

More than 600 companies are currently facing securities class action lawsuits, and over 100 are already paying settlements. Connect your brokerage account to automatically check which ones you may have missed.